Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.47

0.0%

Dec 9 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (459)	12/20/1999 11:19:00 AM
From: scaram(o)uche	Read Replies (1) of 1475

biz.yahoo.com Monday December 20, 10:22 am Eastern Time Company Press Release Robertson Stephens Reiterates Strong Buy Rating on MEDI SAN FRANCISCO--(BUSINESS WIRE)--Dec. 20, 1999--FleetBoston Robertson Stephens Managing Director and Senior Biopharmaceuticals Analyst Jay Silverman today reiterated his Strong Buy rating and raised his target price on Medimmune (NASDAQ:MEDI - news). The company develops important new products that address significant medical needs in areas such as infectious diseases, transplantation medicine, autoimmune diseases and cancer. (snip)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next